#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	11510	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2265	497.9	0	.	n	.	0	C451T	SNP	451	451	C	870	870	T	630	T,C	439,160	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	11510	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2265	497.9	1	SNP	n	C1184T	0	.	.	1184	1184	C	1603	1603	C	608	C,T,A	586,1,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	21852	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3648	588.9	0	.	n	.	0	T695C	SNP	695	695	T	1130	1130	C	661	C	633	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	21852	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3648	588.9	0	.	n	.	0	A1638G	SNP	1638	1638	A	2073	2073	G	731	G,A	537,165	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	21852	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3648	588.9	0	.	n	.	0	T1971C	SNP	1971	1971	T	2406	2406	C	685	C	650	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	21852	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3648	588.9	1	SNP	n	A2045G	0	.	.	2045	2045	A	2480	2480	A	627	A	607	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	21852	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3648	588.9	1	SNP	n	C2597T	0	.	.	2597	2597	C	3032	3032	C	718	C	689	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	1416	folP	855	855	100.0	folP.l15.c4.ctg.1	1597	86.9	1	SNP	p	R229S	1	.	.	685	687	AGC	1017	1019	AGC	154;155;157	A;G;C	149;151;152	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	3836	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3469	108.6	1	SNP	p	S91F	1	.	.	271	273	TTC	600	602	TTC	145;146;145	T;T;C	141;141;140	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	3836	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3469	108.6	1	SNP	p	G95N	0	.	.	283	285	GGC	612	614	GGC	132;131;130	G;G;C	127;125;125	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	3836	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3469	108.6	1	SNP	p	D95G	1	.	.	283	285	GGC	612	614	GGC	132;131;130	G;G;C	127;125;125	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	27	1248	mtrR	633	633	100.0	mtrR.l15.c17.ctg.1	1379	88.8	1	SNP	p	G45D	0	.	.	133	135	GGC	508	510	GGC	176;173;172	G;G;C	165;164;165	mtrR.WHO_G_01393:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	638	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1035	61.1	0	.	n	.	0	A197.	DEL	197	197	A	578	578	A	143	A	138	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3884	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2981	127.9	1	SNP	p	D86N	0	.	.	256	258	GAC	600	602	GAC	138;138;139	G;A,C;C	130;125,1;132	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3884	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2981	127.9	1	SNP	p	S87R	1	.	.	259	261	CGT	603	605	CGT	138;138;139	C,A;G;T,C	129,1;130;128,1	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3884	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2981	127.9	1	SNP	p	R87I	0	.	.	259	261	CGT	603	605	CGT	138;138;139	C,A;G;T,C	129,1;130;128,1	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3884	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2981	127.9	1	SNP	p	R87W	0	.	.	259	261	CGT	603	605	CGT	138;138;139	C,A;G;T,C	129,1;130;128,1	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3884	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2981	127.9	1	SNP	p	S88P	0	.	.	262	264	TCC	606	608	TCC	138;140;141	T;C;C	126;130;130	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	2896	parE	1986	1986	100.0	parE.l6.c4.ctg.1	2652	107.5	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1542	1544	GGC	138;138;140	G;G;C	131;133;135	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.35.001	penA.35.001	1	1	27	2926	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2345	121.8	1	SNP	p	A311V	0	.	.	931	933	GCC	1312	1314	GCC	170;172;171	G;C;C	162;165;163	penA.35.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.35.001	penA.35.001	1	1	27	2926	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2345	121.8	1	SNP	p	I312M	1	.	.	934	936	ATG	1315	1317	ATG	171;171;169	A;T;G	164;164;161	penA.35.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.35.001	penA.35.001	1	1	27	2926	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2345	121.8	1	SNP	p	V316T	1	.	.	946	948	ACC	1327	1329	ACC	159;158;160	A;C;C	153;152;154	penA.35.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.35.001	penA.35.001	1	1	27	2926	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2345	121.8	1	SNP	p	T316P	0	.	.	946	948	ACC	1327	1329	ACC	159;158;160	A;C;C	153;152;154	penA.35.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.35.001	penA.35.001	1	1	27	2926	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2345	121.8	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1828	1830	ACC	140;139;141	A,G;C;C	125,1;128;130	penA.35.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.35.001	penA.35.001	1	1	27	2926	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2345	121.8	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1882	1884	GCG	115;114;114	G;C,G;G,C	107;97,2;98,2	penA.35.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.35.001	penA.35.001	1	1	27	2926	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2345	121.8	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1882	1884	GCG	115;114;114	G;C,G;G,C	107;97,2;98,2	penA.35.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.35.001	penA.35.001	1	1	27	2926	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2345	121.8	1	SNP	p	G542S	0	.	.	1624	1626	GGT	2005	2007	GGT	113;113;112	G;G;T	110;110;105	penA.35.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.35.001	penA.35.001	1	1	27	2926	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2345	121.8	1	SNP	p	G545S	0	.	.	1633	1635	GGC	2014	2016	GGC	99;97;97	G,A;G;C	90,2;95;94	penA.35.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.35.001	penA.35.001	1	1	27	2926	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2345	121.8	1	SNP	p	P551S	0	.	.	1651	1653	CCG	2032	2034	CCG	75;75;72	C,G;C,G;G,A	66,1;67,1;56,1	penA.35.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	4440	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3037	143.6	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1577	1579	CCG	193;189;187	C;C;G	171;177;169	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	1934	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1882	101.0	0	.	p	.	0	M83fs	FSHIFT	247	247	A	534	534	C	134	C	130	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	226	porB1a	984	211	90.52	porB1a.l15.c30.ctg.2	252	21.1	0	.	p	.	0	S271T	NONSYN	811	813	TCG	38	40	ACT	45;43;41	A,C;C;T	24,1;25;25	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	226	porB1a	984	211	90.52	porB1a.l15.c30.ctg.2	252	21.1	0	.	p	.	0	Y273D	NONSYN	817	819	TAT	44	46	GAT	30;29;27	G;A;T	25;25;25	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	226	porB1a	984	211	90.52	porB1a.l15.c30.ctg.2	252	21.1	0	.	p	.	0	D276N	NONSYN	826	828	GAT	53	55	AAC	27;27;27	A;A;C	25;24;25	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	226	porB1a	984	211	90.52	porB1a.l15.c30.ctg.2	252	21.1	0	.	p	.	0	N277H	NONSYN	829	831	AAC	56	58	CAC	27;27;27	C;A;C	25;25;25	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	226	porB1a	984	211	90.52	porB1a.l15.c30.ctg.2	252	21.1	0	.	p	.	0	R307E	NONSYN	919	921	AGA	146	148	GAA	12;12;12	G;A;A	12;12;12	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	226	porB1a	984	211	90.52	porB1a.l15.c30.ctg.2	252	21.1	0	.	p	.	0	T311A	NONSYN	931	933	ACA	158	160	GCA	14;14;13	G;C;A	13;14;13	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	226	porB1a	984	211	90.52	porB1a.l15.c30.ctg.2	252	21.1	0	.	p	.	0	E312D	NONSYN	934	936	GAA	161	163	GAC	13;13;12	G;A;C	13;13;11	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	226	porB1a	984	211	90.52	porB1a.l15.c30.ctg.2	252	21.1	0	.	p	.	0	F314I	NONSYN	940	942	TTC	167	169	ATC	12;12;12	A;T;C	12;12;12	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	226	porB1a	984	211	90.52	porB1a.l15.c30.ctg.2	252	21.1	0	.	p	.	0	A316S	NONSYN	946	948	GCG	173	175	TCG	12;12;13	T;C;G	12;12;13	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	226	porB1a	984	211	90.52	porB1a.l15.c30.ctg.2	252	21.1	0	.	p	.	0	V318A	NONSYN	952	954	GTC	179	181	GCC	13;12;13	G;C;C	13;12;13	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	226	porB1a	984	211	90.52	porB1a.l15.c30.ctg.2	252	21.1	0	.	p	.	0	G319S	NONSYN	955	957	GGC	182	184	AGC	13;13;12	A;G;C	13;13;11	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	226	porB1a	984	211	90.52	porB1a.l15.c30.ctg.2	252	21.1	0	.	p	.	0	G320A	NONSYN	958	960	GGT	185	187	GCC	12;12;12	G;C;C	12;11;12	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	226	porB1a	984	211	90.52	porB1a.l15.c30.ctg.2	252	21.1	0	.	p	.	0	G322V	NONSYN	964	966	GGT	191	193	GTT	13;13;13	G;T;T	13;13;13	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2198	porB1b	1038	1038	99.9	porB1b.l6.c4.ctg.1	1644	131.3	0	.	p	.	0	I45V	NONSYN	133	135	ATT	433	435	GTT	182;181;182	G,A;T;T	174,1;172;175	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2198	porB1b	1038	1038	99.9	porB1b.l6.c4.ctg.1	1644	131.3	1	SNP	p	G120K	1	.	.	358	360	AAG	658	660	AAG	173;170;171	A;A;G,A	170;168;165,1	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2198	porB1b	1038	1038	99.9	porB1b.l6.c4.ctg.1	1644	131.3	1	SNP	p	N121D	0	.	.	361	363	AAC	661	663	AAC	172;170;170	A;A;C	171;169;169	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2198	porB1b	1038	1038	99.9	porB1b.l6.c4.ctg.1	1644	131.3	1	SNP	p	A121N	1	.	.	361	363	AAC	661	663	AAC	172;170;170	A;A;C	171;169;169	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	7584	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4871	152.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	856	rpsJ	312	312	100.0	rpsJ.l15.c30.ctg.1	1151	72.8	1	SNP	p	V57M	1	.	.	169	171	ATG	579	581	ATG	149;149;151	A;T,C;G	143;141,1;145	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
